Janux Therapeutics Inc (JANX)

NASDAQ · Biotechnology

17.66
+0.70 (+4.13%)
Updated Aug 19, 5:47 PM ET
AI Rating
Buy
Overall Score
63
Trend
72
Momentum
67
Risk
44

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Janux Therapeutics Inc is trading at $17.66, up 4.13% on the session. The 50 day average sits at $15.25 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 54.1, which reads as neutral, and MACD is bullish crossover. Volume is below average.

The nearest support is around $15.73 with resistance near $16.53, so that band frames the current range. Average daily movement is roughly $0.63, or about 3.6% of the share price, which is what any stop placement has to allow for. The overall health score of 63 out of 100 combines a trend score of 72, momentum of 67 and a risk score of 44.

Technical indicators

RSI (14)
54.1
neutral
MACD
0.242
bullish crossover
SMA 20
15.81
SMA 50
15.25
SMA 200
--
unknown
ATR (14)
0.63
avg daily range
Support
15.73
Resistance
16.53
Volume vs 20d
0.62x
below average
Volatility
39.5%
annualised
1 month
+1.77%
3 months
+12.02%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.